Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice.
about
Prostaglandins, NSAIDs, and Gastric Mucosal Protection: Why Doesn't the Stomach Digest Itself?Identification of a human enterocyte lipoxin A4 receptor that is regulated by interleukin (IL)-13 and interferon gamma and inhibits tumor necrosis factor alpha-induced IL-8 releaseCyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapyWhy there are two cyclooxygenase isozymes.CXCL17, an orphan chemokine, acts as a novel angiogenic and anti-inflammatory factorReview article: the gastrointestinal safety profile of rofecoxib, a highly selective inhibitor of cyclooxygenase-2, in humansEffect of Helicobacter pylori eradication on cyclooxygenase 2 (COX-2) and inducible nitric oxide synthase (iNOS) expression during gastric adaptation to aspirin (ASA) in humansClassic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcersDelay in oral mucosal ulcer healing by aspirin is linked to the disturbances in p38 mitogen-activated protein kinase activationManagement of peptic ulcer disease not related to HelicobacterCurrent approaches to prevent NSAID-induced gastropathy--COX selectivity and beyondSurface phospholipids in gastric injury and protection when a selective cyclooxygenase-2 inhibitor (Coxib) is used in combination with aspirinSelective cyclo-oxygenase-2 inhibitors aggravate ischaemia-reperfusion injury in the rat stomachSelective cyclo-oxygenase-2 inhibition with celecoxib elevates blood pressure and promotes leukocyte adherenceEffects of specific inhibition of cyclo-oxygenase-1 and cyclo-oxygenase-2 in the rat stomach with normal mucosa and after acid challengePlaunotol prevents indomethacin-induced gastric mucosal injury in rats by inhibiting neutrophil activationCyclooxygenase-2/prostaglandin E2 accelerates the healing of gastric ulcers via EP4 receptorsThe effect of NSAIDs and a COX-2 specific inhibitor on Helicobacter pylori-induced PGE2 and HGF in human gastric fibroblasts.COX-1 and COX-2 conversely promote and suppress ischemia-reperfusion gastric injury in mice.Integrative roles of transforming growth factor-alpha in the cytoprotection mechanisms of gastric mucosal injuryThe incidence of adverse events and risk factors for upper gastrointestinal disorders associated with meloxicam use amongst 19,087 patients in general practice in England: cohort studyThree-dimensional tissue assemblies: novel models for the study of Salmonella enterica serovar Typhimurium pathogenesis.NSAID-induced antral ulcers are associated with distinct changes in mucosal gene expression.When to try COX-2-specific inhibitors. Safer than standard NSAIDs in some situations.Basic biology and clinical application of specific cyclooxygenase-2 inhibitors.Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2.An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group.Effects of nonsteroidal anti-inflammatory drugs on Helicobacter pylori-infected gastric mucosae of mice: apoptosis, cell proliferation, and inflammatory activity.Aspirin and other anti-inflammatory drugs.Divergent effects of new cyclooxygenase inhibitors on gastric ulcer healing: Shifting the angiogenic balance.Celecoxib: a new option in the treatment of arthropathies and familial adenomatous polyposis.Cancer-stromal cell interaction and tumor angiogenesis in gastric cancerCyclooxygenase inhibitors: any reservations?Cyclooxygenase 2-implications on maintenance of gastric mucosal integrity and ulcer healing: controversial issues and perspectivesH(2)S-releasing aspirin protects against aspirin-induced gastric injury via reducing oxidative stress.Cyclooxygenase (COX) 1 and 2 in normal, inflamed, and ulcerated human gastric mucosa.Historical lessons in translational medicine: cyclooxygenase inhibition and P2Y12 antagonism.Muc-2-deficient mice display a sex-specific, COX-2-related impairment of gastric mucosal repair.Enhanced synthesis and diminished degradation of hydrogen sulfide in experimental colitis: a site-specific, pro-resolution mechanism.Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants.
P2860
Q22306448-AE8CFC3F-737D-4DE9-8F81-949A503BE460Q24647299-0BEB740A-BE08-456E-9B3E-1EACD752C9FEQ24675327-080DB909-C068-44C0-A960-3F6F91B4572DQ27863307-9A7AC203-CC58-4A13-829D-A125E3DD48A7Q28116204-2DE12512-AD03-4ADF-B334-CEC2D92E3DADQ28174827-F4A4D8E0-4E04-4013-A035-1AA29D3800E5Q28184229-FB3DC5C5-39AD-4F26-9143-092F045C32F4Q28184249-F05B7E59-14F7-4FE6-A2BF-405F71556C2DQ28186400-3D381452-DA64-4CC3-BB10-78B9096E77D9Q28192901-68434D27-6E57-4897-8EE9-CACAA1CB75C6Q28210656-9EA1BAA1-F6A6-4FE9-92DA-FCAA77F25BADQ28219464-DADE7AA6-1F00-437E-A3AA-57D1134786AFQ28343775-6D65143C-571E-47F7-B2FB-048472E916A5Q28344081-6B70B09D-CC83-4173-91E6-F931096526C8Q28361239-212A3C91-9EE5-4F1C-91C6-B09CB8F0D72BQ28374016-8F139573-3652-4818-8DB0-B92EBB176989Q28573632-56898766-DA7F-4519-910A-37FA9D0F45C9Q31371704-616B27CA-209C-4A08-B42A-649C03C7DBA7Q33223568-5CC7974C-16A8-4217-992D-85FBC20EFB35Q33252380-BDD4FB0A-3C19-48E1-A1DA-FDE789AC52AFQ33333061-71C61A25-BD2C-448D-B81F-B828B49ED449Q33553824-05381BD4-9C8D-4F2D-BCDA-F7F8582D47E9Q33701847-66006FF1-87FB-4E96-8DBF-EFB330C71364Q33758859-C6E53209-5EAA-4D8C-94D3-295DA3530433Q33822140-6FEFDF3C-7D0B-4321-9DE3-385CE025C420Q33938703-01D013A0-11C5-488A-8E52-95AC71A74B85Q33952311-2E05CAF6-A27C-4192-816B-438E97890655Q34008670-112B60FB-7FE5-44F0-A944-518CAF27C1BCQ34036177-09FE53E3-3B6E-4069-AE88-5B62B7820327Q34192374-B61D7F2C-D68B-4ED4-9118-EA0EE20BB7E4Q34240778-9AD1C521-8814-4D50-A325-2AAF6F3F7A1AQ34268727-D4D099C1-BCF0-4AF3-B01B-4B9F77A388A6Q34322409-956FFB46-2A3D-44FB-AE34-08622F03DB13Q34340684-8145AF68-AC91-4421-A915-CEC21E10F8C6Q34431045-19FB748B-534D-4682-9E96-27EDE49DB936Q34511855-823240A9-228C-4A79-877E-69C19F277627Q34536091-AC95DAAC-4CFC-4001-A419-66AFBEE4D46FQ34756209-D157EA13-F89F-49BA-B90E-13FE18570293Q34938166-446C8BE2-9384-439D-AF34-5171BC0DF31DQ35042271-8277F1C9-39B0-46B5-A088-E19A215C4097
P2860
Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Induction of cyclooxygenase 2 ...... gonist delays healing in mice.
@en
Induction of cyclooxygenase 2 ...... gonist delays healing in mice.
@nl
type
label
Induction of cyclooxygenase 2 ...... gonist delays healing in mice.
@en
Induction of cyclooxygenase 2 ...... gonist delays healing in mice.
@nl
prefLabel
Induction of cyclooxygenase 2 ...... gonist delays healing in mice.
@en
Induction of cyclooxygenase 2 ...... gonist delays healing in mice.
@nl
P2093
P1433
P1476
Induction of cyclooxygenase 2 ...... gonist delays healing in mice.
@en
P2093
Akamatsu T
Sakamoto C
P304
P356
10.1053/GAST.1997.V112.PM9024292
P407
P577
1997-02-01T00:00:00Z